News & Updates

The combination of atezolizumab and bevacizumab is better than sorafenib at maintaining clinically meaningful survival benefits over the long term in patients with unresectable hepatocellular carcinoma (HCC), reports a recent update to the IMbrave150 study.

Extracellular vesicles enriched with the polymeric immunoglobulin receptor molecule contributes to tumorigenesis and cancer stemness in patients with hepatocellular carcinoma (HCC), reports a recent study.

A moderate increase in the consumption of foods rich in isoflavone can help reduce the risk of lung cancer in women with no smoking history, suggests a study.

Obesity during early adulthood seems to significantly aggravate the risk of early-onset colorectal cancer (CRC), reports a recent study.

Patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) who have been initiated on apalutamide in a real-world setting appear to show prostate-specific antigen (PSA) response that is strong and consistent with that reported in clinical trials, as reported in a study.

Breast cancer survival has been improving greatly over the last 14 years, an effect attributable to advancements in systemic therapy, a recent Korea study has found.

Meat eaters can rejoice in knowing that they are not at greater risk of developing total gastric cancer, according to a cohort study in Japan.